首页> 外文期刊>South African medical journal: Suid-Afrikaanse tydskrif vir geneeskunde >MEDICINE AND THE LAW Pre-implantation diagnosis to create 'saviour siblings': A critical discussion of the current and future legal frameworks in South Africa
【24h】

MEDICINE AND THE LAW Pre-implantation diagnosis to create 'saviour siblings': A critical discussion of the current and future legal frameworks in South Africa

机译:医学与法律植入前诊断可创造“救世主兄弟姐妹”:对南非当前和未来法律框架的批判性讨论

获取原文
获取原文并翻译 | 示例
       

摘要

Pre-implantation genetic diagnosis (PGD) is a technology used in conjunction with in vitro fertilisation to screen embryos for genetic conditions prior to transfer. It was initially developed to screen mutations for severe, irreversible, genetic conditions. Currently, PGD makes it possible to select against more than 100 different genetic conditions. It has been proposed as a method for creating a tissue-matched child who can in turn serve as a compatible stem cell donor to save a sick sibling in need of a stem cell transplant. The advantage of this method is that it provides genetic information before implantation of an embryo into the womb, making it possible to ensure that only tissue-matched embryos are transferred to the uterus. A couple can therefore avoid the difficult choice of either terminating the pregnancy at a later point if the fetus is not a match, or extending their family again in the hope that their next child will be tissue compatible. Many people have expressed disapproval of the use of PGD for this purpose, and it is associated with many conflicting interests including religion, ethics as well as legal regulation. In order to manage these issues some jurisdictions have created legal frameworks to regulate the use of this technology. Many of these are modelled on the UK's Human Fertilisation and Embryology Authority and its guardian legislation. This paper critiques the current and future South African legal framework to establish whether it is able to adequately regulate the use of PGD as well as guard against misuse of the technology. It concludes that changes are required to the future framework in order to ensure that it regulates the circumstances in which PGD may occur and that the Minister of Health should act expediently in finalising draft regulations which will regulate PGD in the future.
机译:植入前遗传学诊断(PGD)是一项与体外受精结合使用的技术,用于在移植前对胚胎进行遗传条件筛查。它最初是为筛选严重,不可逆的遗传条件的突变而开发的。目前,PGD可以针对100多种不同的遗传条件进行选择。已经提出了一种用于创建组织匹配的孩子的方法,该孩子可以继而用作相容的干细胞供体,以节省需要干细胞移植的患病同胞。这种方法的优势在于,它可以在将胚胎植入子宫之前提供遗传信息,从而可以确保仅将组织匹配的胚胎转移到子宫中。因此,一对夫妇可以避免艰难的选择,即如果胎儿不匹配则在较晚的时间终止妊娠,或者再次扩大家庭,以期他们的下一个孩子将与组织相容。许多人表示不赞成将PGD用于此目的,它与许多相互冲突的利益相关,包括宗教,道德和法律法规。为了解决这些问题,一些司法管辖区创建了法律框架来规范该技术的使用。其中许多是仿照英国的人类受精和胚胎学管理局及其监护人立法制定的。本文对当前和未来的南非法律框架进行了批评,以确定它是否能够充分规范PGD的使用并防止滥用该技术。结论是,需要对未来框架进行更改,以确保它规范可能发生PGD的情况,并且卫生部长应为确定将来规管PGD的法规草案尽责而为。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号